Van Andel Institute

2017–2022 · research · R35

Molecular mechanisms of chromatin and epigenetic regulation

Scott Rothbart · Van Andel Institute · funded by National Institutes of Health

$475kEpigenetics and DNA Methylation

2017–2022 · research · R01

Analyzing the role of TXNIP as a universal regulator of glucose transport

Ning Wu · Van Andel Institute · funded by National Institutes of Health

$399kMetabolism, Diabetes, and Cancer

2017–2022 · research · R35

Molecular mechanisms of chromatin and epigenetic regulation

Scott Rothbart · Van Andel Institute · funded by National Institutes of Health

$475kEpigenetics and DNA Methylation

2017–2022 · research · R01

Analyzing the role of TXNIP as a universal regulator of glucose transport

Ning Wu · Van Andel Institute · funded by National Institutes of Health

$399kMetabolism, Diabetes, and Cancer

2017–2019 · research · R21

Developing novel treatments for Parkinson's disease by targeting molecular pathways that have been shown to modulate aging

Darren John Moore · Van Andel Institute · funded by National Institutes of Health

$285k

2017–2022 · research · R35

Molecular mechanisms of chromatin and epigenetic regulation

Scott Rothbart · Van Andel Institute · funded by National Institutes of Health

$475kEpigenetics and DNA Methylation

2017–2022 · research · R01

Mechanisms of VPS35-Dependent Neurodegeneration in Parkinson's Disease

Darren John Moore · Van Andel Institute · funded by National Institutes of Health

$415.6kParkinson's Disease Mechanisms and Treatments

2017–2021 · research · R01

Visualization and Epigenomic Characterization of Early Intestinal Tumorigenesis in Mice

Peter W Laird · Van Andel Institute · funded by National Institutes of Health

$434.6k

2017–2019 · research · R21

Detecting alpha-synuclein aggregates

Jiyan Ma · Van Andel Institute · funded by National Institutes of Health

$285kParkinson's Disease Mechanisms and Treatments

2017–2021 · research · R01

Visualization and Epigenomic Characterization of Early Intestinal Tumorigenesis in Mice

Peter W Laird · Van Andel Institute · funded by National Institutes of Health

$434.6k

2017–2020 · fellowship · F31

The Role of Polycomb Target Gene DNA Methylation in Intestinal Tumorigenesis

Nicole Vander Schaaf · Van Andel Institute · funded by National Institutes of Health

$43kEpigenetics and DNA Methylation

2017–2023 · research · R35

Targeting DNA Methylation and the Cancer Epigenome

Peter A Jones · Van Andel Institute · funded by National Institutes of Health

$1.1MEpigenetics and DNA Methylation

2017–2022 · research · R01

Analyzing the role of TXNIP as a universal regulator of glucose transport

Ning Wu · Van Andel Institute · funded by National Institutes of Health

$399kMetabolism, Diabetes, and Cancer

2017–2019 · award

D620N VPS35 knockin mice: a new model of familial Parkinson’s disease

Xi Chen · Van Andel Institute · funded by Parkinson's Foundation

110k

2017–2019 · research · R01

Cryo-EM of the Eukaryotic Replisome

Huilin Li · Van Andel Institute · funded by National Institutes of Health

$372.9kDNA Repair Mechanisms

2017–2021 · research · R01

Visualization and Epigenomic Characterization of Early Intestinal Tumorigenesis in Mice

Peter W Laird · Van Andel Institute · funded by National Institutes of Health

$434.6k

2017–2022 · research · R01

Linking Synucleinopathy and Dysfunction of Olfactory Pathways

Patrik Brundin · Van Andel Institute · funded by National Institutes of Health

$560.7kOlfactory and Sensory Function Studies

2017–2018 · research · R01

Molecular mechanisms by which mild elevation of mitochondrial superoxide extends lifespan

Jeremy Michael Van Raamsdonk · Van Andel Institute · funded by National Institutes of Health

$351.5kGenetics, Aging, and Longevity in Model Organisms

2017–2022 · research · R35

Molecular mechanisms of chromatin and epigenetic regulation

Scott Rothbart · Van Andel Institute · funded by National Institutes of Health

$475kEpigenetics and DNA Methylation

2017–2030 · research · R35

Establishing and Interpreting Abnormal DNA Methylation in Cancer

Peter A Jones · Van Andel Institute · funded by National Institutes of Health

$1.1M

2017–2023 · research · R01

Mechanisms of VPS35-Dependent Neurodegeneration in Parkinson's Disease

Darren John Moore · Van Andel Institute · funded by National Institutes of Health

$415.6kParkinson's Disease Mechanisms and Treatments

2017–2020 · fellowship · F31

The Role of Polycomb Target Gene DNA Methylation in Intestinal Tumorigenesis

Nicole Vander Schaaf · Van Andel Institute · funded by National Institutes of Health

$43.5kEpigenetics and DNA Methylation

2017–2023 · research · R35

Targeting DNA Methylation and the Cancer Epigenome

Peter A Jones · Van Andel Institute · funded by National Institutes of Health

$1.1MEpigenetics and DNA Methylation

2017–2021 · research · R01

Cryo-EM of the Eukaryotic Replisome

Huilin Li · Van Andel Institute · funded by National Institutes of Health

$372.9kDNA Repair Mechanisms

2017–2030 · research · R35

Establishing and Interpreting Abnormal DNA Methylation in Cancer

Peter A Jones · Van Andel Institute · funded by National Institutes of Health

$1.1M

2017–2022 · research · R01

Mechanisms of VPS35-Dependent Neurodegeneration in Parkinson's Disease

Darren John Moore · Van Andel Institute · funded by National Institutes of Health

$415.6kParkinson's Disease Mechanisms and Treatments

2017–2022 · research · R01

Linking Synucleinopathy and Dysfunction of Olfactory Pathways

Patrik Brundin · Van Andel Institute · funded by National Institutes of Health

$571.8k

2017–2022 · research · R01

Linking Synucleinopathy and Dysfunction of Olfactory Pathways

Darren John Moore · Van Andel Institute · funded by National Institutes of Health

$544.4kOlfactory and Sensory Function Studies

2017–2023 · research · R35

Targeting DNA Methylation and the Cancer Epigenome

Peter A Jones · Van Andel Institute · funded by National Institutes of Health

$1.1MEpigenetics and DNA Methylation

2017–2030 · research · R35

Establishing and Interpreting Abnormal DNA Methylation in Cancer

Peter A Jones · Van Andel Institute · funded by National Institutes of Health

$1M

2016 · research · Target Advancement Program

Role of GTPase Activity in Neurodegenerative Phenotypes Induced by G2019S LRRK2 in a Pre-clinical Model of Parkinson’s Disease

Darren J. Moore · Van Andel Institute · funded by Michael J. Fox Foundation for Parkinson's Research

2016–2018 · research · R21

Does Microglial Activation Influence Propagation of Alpha-synuclein Pathology

Patrik Brundin · Van Andel Institute · funded by National Institutes of Health

$285kParkinson's Disease Mechanisms and Treatments

2016–2018 · grant · PCRP

Notch Signaling in Prostate Cancer Cells Promotes Osteoblastic Metastasis

Sourik Ganguly · Van Andel Institute · funded by Congressionally Directed Medical Research Programs

$237.5k

2016–2018 · research · R21

On-chip Glycan Analysis of Clinical Specimens

Brian B. Haab · Van Andel Institute · funded by National Institutes of Health

$304.6kGlycosylation and Glycoproteins Research

2016–2021 · research · R01

Role of GAS41 in Human Cancer

Xiaobing Shi · Van Andel Institute · funded by National Institutes of Health

$391.2k

2016–2021 · cooperative agreement · U24

Integrative Cancer Epigenomic Data Analysis Center (ICE-DAC)

Benjamin P Berman · Van Andel Institute · funded by National Institutes of Health

$489.4kEpigenetics and DNA Methylation

2016–2021 · cooperative agreement · U24

Integrative Cancer Epigenomic Data Analysis Center (ICE-DAC)

Benjamin P Berman · Van Andel Institute · funded by National Institutes of Health

$527k

2016–2021 · cooperative agreement · U24

Integrative Cancer Epigenomic Data Analysis Center (ICE-DAC)

Peter W Laird · Van Andel Institute · funded by National Institutes of Health

$504.5kEpigenetics and DNA Methylation

2016–2018 · research · R01

Structure Biology of Mycobacterium Tuberculosis Pup-Proteasome Pathway

Huilin Li · Van Andel Institute · funded by National Institutes of Health

$475kUbiquitin and proteasome pathways

2016–2018 · research · R21

On-chip Glycan Analysis of Clinical Specimens

Brian B. Haab · Van Andel Institute · funded by National Institutes of Health

$326.4kGlycosylation and Glycoproteins Research